Trial Profile
Phase I Study to Investigate Pharmacodynamics of CJ-12420 Compared to Dexlansoprazole With Evening Dosing
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Tegoprazan (Primary) ; Dexlansoprazole
- Indications Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Sponsors CJ HealthCare; HK inno.N
- 09 Feb 2017 New trial record